Position
SIMPLEX TRADING, LLC in Outlook Therapeutics, Inc.
Back to the book · All holders of OTLK
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$145.4K$1.58 → $0.21
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 105.8K | $167.2K | — | — | — | 0.0% |
| Q1 2026 | 132.7K | $27.3K | $0.21 | −$145.4K | $5.53K | 0.0% |